USMLE Reproductive: Prostate Cancer, PSA, Gleason Score, Bone Mets, Treatment

What This Is and Why It Matters for USMLE

Prostate Cancer is a high-yield topic for Step 1, Step 2 CK, and Step 3. It is frequently tested in basic science, clinical, and management contexts. Understanding the pathophysiology, diagnostic approach, and treatment options is crucial for medical students preparing for the USMLE.

High-Yield Facts (What You Must Memorize)

• Prostate Cancer: Most common non-skin cancer in men, accounting for 15% of cancer deaths.
• Risk Factors: Age, family history, African American descent, high-fat diet.
• Classic Presentation: Asymptomatic, palpable nodule on digital rectal exam (DRE).
• Diagnostic Approach:
  • PSA (Prostate-Specific Antigen): Elevated in 70% of cases.
  • Biopsy: Confirms diagnosis, grades cancer using Gleason Score.
  • Imaging: CT, MRI for staging and monitoring.
• First-Line Treatment:
  • Watchful Waiting: Observation for low-risk patients.
  • Active Surveillance: Regular PSA, DRE, and biopsy for intermediate-risk patients.
  • Surgery: Radical prostatectomy for localized disease.
  • Radiation: External beam radiation therapy (EBRT) for localized disease.
• Red Flags: Rapidly rising PSA, palpable nodule, weight loss.
• Complications: Urinary incontinence, erectile dysfunction, bone metastases.

Clinical Pearls & Buzzwords

• PSA Velocity: Rapid increase in PSA levels.
• Gleason Score: Histological grading system (2-10).
• Bone Mets: Metastases to bone, often causing pain and hypercalcemia.

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation: Asymptomatic, palpable nodule on DRE.
2. Generate a differential: Benign prostatic hyperplasia (BPH), prostatitis, prostate cancer.
3. Order appropriate initial tests: PSA, DRE, biopsy.
4. Interpret results: Elevated PSA, confirmatory biopsy.
5. Initiate treatment and monitoring: Watchful waiting, active surveillance, or surgery/radiation.

Missing a rapidly rising PSA can lead to delayed diagnosis and treatment.

Common Mistakes & Exam Traps

• The mistake: Failing to consider prostate cancer in a patient with a palpable nodule.
• Why it happens: Rushing through the exam or not considering the patient's age and risk factors.
• How to avoid it: Take your time, consider the patient's risk factors, and order appropriate initial tests.

• Exam board insight: The examiners want to test your ability to think critically and consider the patient's overall clinical picture.

• The mistake: Not ordering a biopsy in a patient with an elevated PSA.

• Why it happens: Misunderstanding the importance of biopsy in diagnosing prostate cancer.
• How to avoid it: Remember that biopsy is the gold standard for diagnosing prostate cancer.
• Exam board insight: The examiners want to test your knowledge of the diagnostic approach to prostate cancer.

How It’s Tested on USMLE

• Step 1: Basic science vignette, e.g., molecular mechanism of prostate cancer, pathology slide.
• Step 2 CK: Clinical vignette, e.g., "A 65-year-old man presents with a palpable nodule on DRE."
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and CCS management.

CCS (Step 3) Relevance (If Applicable)

• Initial orders: Order a PSA, DRE, and biopsy to confirm the diagnosis.
• Monitoring and follow-up: Regular PSA, DRE, and biopsy to monitor the patient's response to treatment.
• Common mistakes: Not ordering a biopsy, delaying treatment.

Practice Questions (3-5 single-best-answer)

Question 1: A 65-year-old man presents with a palpable nodule on DRE. His PSA is 10 ng/mL. What is the next best step in management? Options: A) Order a biopsy, B) Start radiation therapy, C) Perform a DRE, D) Order a CT scan. Answer: A) Order a biopsy. Explanation: The patient's age and elevated PSA make prostate cancer a likely diagnosis. A biopsy is the gold standard for diagnosing prostate cancer.

Question 2: A patient is diagnosed with prostate cancer and has a Gleason score of 7. What is the prognosis? Options: A) Good, B) Fair, C) Poor, D) Uncertain. Answer: C) Poor. Explanation: A Gleason score of 7 indicates a high-grade tumor, which has a poor prognosis.

Question 3: A patient is diagnosed with prostate cancer and has bone metastases. What is the treatment? Options: A) Surgery, B) Radiation therapy, C) Hormone therapy, D) Chemotherapy. Answer: C) Hormone therapy. Explanation: Hormone therapy is the treatment of choice for prostate cancer with bone metastases.

Quick Reference Card (60-Second Summary)

• PSA: Elevated in 70% of cases.
• Gleason Score: Histological grading system (2-10).
• Bone Mets: Metastases to bone, often causing pain and hypercalcemia.
• First-Line Treatment: Watchful waiting, active surveillance, surgery, or radiation therapy.
• Red Flags: Rapidly rising PSA, palpable nodule, weight loss.

If You Get Stuck on Test Day

• Eliminate obviously wrong answers: Use the process of elimination to narrow down the options.
• Use the "next best step" hierarchy: Start with the least invasive option and work your way up.
• For Step 3 CCS: Order basic labs, vitals, and IV access when unsure.

Related USMLE Topics

• Benign Prostatic Hyperplasia (BPH): Connects to prostate cancer through shared risk factors and symptoms.
• Prostatitis: Connects to prostate cancer through shared symptoms and diagnostic approach.
• Androgen Deprivation Therapy: Connects to prostate cancer through treatment options and side effects.